Minor
LUNAR-2 · TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Trial sites expanded: 98 → 104 locations
NovoCure GmbHPhase 3 NCT06216301 Registry history of NCT06216301 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 98 → 104 locations
NovoCure GmbHPhase 3 NCT06216301 Registry history of NCT06216301 on ClinicalTrials.gov (opens the registry)
| Phase 3 | 2 |
Glioblastoma (1) · Glioma (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)